CLINICAL_TRIALS
trial_result
· 2009-03-19
Clinical Trial Update: A Study of Enzastaurin in Patients With Leukemia [Phase 1]
Summary
This document reports results from a Phase 1 study of enzastaurin in patients with lymphocytic leukemia. The trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Leukemia, Lymphocytic | Phase 1 | Status: COMPLETED